References
Sunyach MP, Jouvet A, Perol D, Jouanneau E, Guyotat J, Gignoux L et al (2007) Role of exclusive chemotherapy as first line treatment in oligodendroglioma. J Neurooncol Jun 14; [Epub ahead of print]
Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M et al (2003) Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 65(3):259–266
Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24(18):2707–2714
Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA (1993) The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32(3):365–370
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kyritsis, A.P., Puduvalli, V.K. & Levin, V.A. Chemotherapy as first line treatment for oligodendroglioma. J Neurooncol 86, 361–362 (2008). https://doi.org/10.1007/s11060-007-9465-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9465-5